[ad_1]
The Sputnik V vaccine showed a 92% effective in protecting people from the new coronavirusaccording to interim results released by Russian health officials on Wednesday.
The advanced figure is based on data collected from a sample of 16,000 participants who received two doses of the vaccine. However, the third phase of trials for this treatment developed by the Gamaleya Institute is still being carried out in 29 clinics in Moscow, for a total of 40,000 volunteers, a quarter of whom will receive a placebo.
The study has been funded by the Russian Direct Investment Fund (RDIF), which says that the chances that someone who received this vaccine will contract the virus is 92% lower than those who received a placebo. A percentage that remains above 50% efficacy of the vaccine required by the US Food and Drug Administration (FDA).
“We are proving, based on the data, that we have a very effective vaccine,” says RDIF president Kirill Dmitiev, quoted by Reuters, adding that this was the kind of story that those who developed the vaccine would one day tell to his grandchildren. .
This forecast is the second to be published in the race to cure the new coronavirus, as Russia is making efforts to keep up with Western pharmaceutical companies, such as Pfizer, which also announced a 90% effective drug on Tuesday.
Russia is preparing the third vaccine against Covid-19, says Putin
The two vaccines with proven efficacy to date have been designed using different methods: while Pfizer’s uses mRNA technology and is prepared to activate an immune response without resorting to the use of pathogens, Sputnik V activates a response to the two vaccines, administered with Interval of 21 days in different vectors, which cause the “common” flu.
Announced in August, becoming the first in the fight against Covid-19, the Russian vaccine has been questioned until today, and in September the British magazine The Lancet even asked for clarification due to doubts about the veracity of clinical trials. .
COVID-19. Lancet magazine asks for clarification on Russian vaccine
